New innovation for recombinant antibodies that can help improve bioanalytical assays

In this interview Paul Royle (Technical Sales Manager, Bio-Rad Laboratories, UK) discusses the use of HuCAL® technology, which is a method of generating recombinant monoclonal antibodies using a synthetic antibody library and phage display. He explains how Bio-Rad has recently introduced SpyTag-SpyCatcher technology into the process, which enables site-specific antibody conjugation and rapid assembly of different antibody formats, and how this innovation can benefit bioanalysts.

Questions include:

1What is HuCAL® technology?

custom antibodies-bio-rad2Tell us about Bio-Rad’s innovation for recombinant antibodies

3How is SpyTag technology of benefit to bioanalysts?

4What do you see as the future developments in this area?

Click here to learn more about Bio-Rad

You may also be interested in…

Ulrich_mayerGenerating custom antibodies for bioanalytical research: an interview with Ulrich Mayer
In this interview Ulrich Mayer, Technical Sales Specialist (Bio-Rad Laboratories, CA, USA) discusses Bio-Rad’s custom recombinant antibody generation capabilities. Mayer explains why global biopharmaceutical companies and CROs choose Bio-Rad for the generation of custom antibodies targeting different types of large molecule drugs and CAR-T cell therapies. Mayer also describes the technology behind Bio-Rad’s custom antibody service, as well as commenting on what the future may hold for the partnership between Bio-Rad and bioanalytical scientists.

In the Zone: CAR-T cellsCAR-T
In this feature, we will investigate some of the trials and tribulations associated with researching and developing CAR-T cell therapies. We will also be looking at what the future may hold for the treatment and what benefits we may expect to see from furthering the development of immunotherapies.